Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Durham

Allergy

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Allergy|June 15, 2011
Sustained effects of grass pollen AITS R Durham,
Allergy|February 1, 2005
Epidemiological characterization of the intermittent and persistent types of allergic rhinitisV Bauchau, S R Durham
Allergy|July 11, 2007
Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockageS R Durham, B Riis
Allergy|April 9, 2005
Monophosphoryl lipid A (MPL) promotes allergen-induced immune deviation in favour of Th1 responsesF Puggioni, S R Durham, J N Francis
Allergy|July 9, 2010
Days with severe symptoms: an additional efficacy endpoint in immunotherapy trialsS R Durham, A O Birk, J S Andersen
Allergy|December 4, 2004
Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysisD R Wilson, M Torres Lima, S R Durham
Allergy|July 11, 2007
Prolonged preseasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacyM A Calderon, A O Birk, J S Andersen, et al.
Allergy|August 24, 2007
Effect of grass pollen immunotherapy with Alutard SQ on quality of life in seasonal allergic rhinoconjunctivitisR J Powell, A J Frew, C J Corrigan, et al.
Allergy|May 1, 1995
Grass pollen immunotherapy: efficacy and safety during a 4-year follow-up studyS M Walker, V A Varney, M Gaga, et al.
Allergy|December 13, 2006
T lymphocytes expressing CCR3 are increased in allergic rhinitis compared with non-allergic controls and following allergen immunotherapyJ N Francis, C M Lloyd, I Sabroe, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Allergy|June 15, 2011
Sustained effects of grass pollen AITS R Durham,
Allergy|February 1, 2005
Epidemiological characterization of the intermittent and persistent types of allergic rhinitisV Bauchau, S R Durham
Allergy|July 11, 2007
Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockageS R Durham, B Riis
Allergy|April 9, 2005
Monophosphoryl lipid A (MPL) promotes allergen-induced immune deviation in favour of Th1 responsesF Puggioni, S R Durham, J N Francis
Allergy|July 9, 2010
Days with severe symptoms: an additional efficacy endpoint in immunotherapy trialsS R Durham, A O Birk, J S Andersen
Allergy|December 4, 2004
Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysisD R Wilson, M Torres Lima, S R Durham
Allergy|July 11, 2007
Prolonged preseasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacyM A Calderon, A O Birk, J S Andersen, et al.
Allergy|August 24, 2007
Effect of grass pollen immunotherapy with Alutard SQ on quality of life in seasonal allergic rhinoconjunctivitisR J Powell, A J Frew, C J Corrigan, et al.
Allergy|May 1, 1995
Grass pollen immunotherapy: efficacy and safety during a 4-year follow-up studyS M Walker, V A Varney, M Gaga, et al.
Allergy|December 13, 2006
T lymphocytes expressing CCR3 are increased in allergic rhinitis compared with non-allergic controls and following allergen immunotherapyJ N Francis, C M Lloyd, I Sabroe, et al.
Pageof 5